Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene & Lorenzo Galluzzi. (2017) Trial watch: DNA-based vaccines for oncological indications. OncoImmunology 6:12.
Read now
Read now
Claire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, Fernando Aranda, Takahiro Yamazaki, Oliver Kepp, Jitka Fucikova, Radek Spisek, Sandra Demaria, Silvia C. Formenti, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immune checkpoint blockers for cancer therapy. OncoImmunology 6:11.
Read now
Read now
Justin M. David, Charli Dominguez, Kristen K. McCampbell, James L. Gulley, Jeffrey Schlom & Claudia Palena. (2017) A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. OncoImmunology 6:10.
Read now
Read now
Audrey Bouillez, Dennis Adeegbe, Caining Jin, Xiufeng Hu, Ashujit Tagde, Maroof Alam, Hasan Rajabi, Kwok-Kin Wong & Donald Kufe. (2017) MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer. OncoImmunology 6:9.
Read now
Read now
Articles from other publishers (42)
Kenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, Mitsuru Fukui, Akira Sugimoto, Hiroaki Nagamine, Koichi Ogawa, Kenji Sawa, Yoko Tani, Hiroyasu Kaneda, Shigeki Mitsuoka, Tetsuya Watanabe, Kazuhisa Asai & Tomoya Kawaguchi. (2023) Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer. Cancer Chemotherapy and Pharmacology 92:5, pages 381-390.
Crossref
Crossref
Madeline Dahut, Kristen Fousek, Lucas A Horn, Shantel Angstadt, Haiyan Qin, Duane H Hamilton, Jeffrey Schlom & Claudia Palena. (2023) Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis. Journal for ImmunoTherapy of Cancer 11:9, pages e007386.
Crossref
Crossref
Ashu Shah, Sanjib Chaudhary, Imayavaramban Lakshmanan, Abhijit Aithal, Sophia G. Kisling, Claire Sorrell, Saravanakumar Marimuthu, Shailendra K. Gautam, Sanchita Rauth, Prakash Kshirsagar, Jesse L. Cox, Gopalakrishnan Natarajan, Rakesh Bhatia, Kavita Mallya, Satyanarayana Rachagani, Mohd Wasim Nasser, Apar Kishor Ganti, Ravi Salgia, Sushil Kumar, Maneesh Jain, Moorthy P. Ponnusamy & Surinder K. Batra. (2023) Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies. npj Precision Oncology 7:1.
Crossref
Crossref
Yi Cao, Yunjin Li, Ruijie Liu, Jianhua Zhou & Kuansong Wang. (2023) Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer. Cancers 15:9, pages 2568.
Crossref
Crossref
Yuanzhuo Gu, Zhengkui Zhang & Peter ten Dijke. (2023) Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy. Cellular & Molecular Immunology 20:4, pages 318-340.
Crossref
Crossref
Breno Queiroz Pinheiro, Francisco Felipe de Magalhães, Francisco Wesley da Silva Alves, Isaac Neto Goes Silva, Augusto Manuel Rodrigues Faustino & Lúcia Daniel Machado da Silva. (2023) CA 15-3, CRP, and LDH correlates with prognostic parameters in canine mammary neoplasms. Animal Reproduction 20:1.
Crossref
Crossref
Weiqiu Jin, Mengwei Zhang, Changzi Dong, Lei Huang & Qingquan Luo. (2022) The multifaceted role of MUC1 in tumor therapy resistance. Clinical and Experimental Medicine 23:5, pages 1441-1474.
Crossref
Crossref
. (2022) Evaluation of Serum Hormones and Biochemical Tumor Markers among Breast Cancer Patients in the South-South Region, Nigeria. European Journal of Medical and Health Sciences, pages 191-200.
Crossref
Crossref
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, Saman Sargazi, Abbas Rahdar & Ana M. Díez-Pascual. (2022) Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches. Journal of Controlled Release 349, pages 844-875.
Crossref
Crossref
Riley D.Z. Mullins, Ananya Pal, Thomas F. Barrett, Molly E. Heft Neal & Sidharth V. Puram. (2022) Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion. Cancer Research 82:13, pages 2329-2343.
Crossref
Crossref
Yan Zhang, Jing Zhao, Yajun Wang, Wei Cai, Xiaoli Zhang, Kaifu Li, Wenqing Liu, Ye Zhao & Hua Kang. (2022) Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy. Disease Markers 2022, pages 1-14.
Crossref
Crossref
Katelyn N Seale & Katherine H R Tkaczuk. (2022) Circulating Biomarkers in Breast Cancer. Clinical Breast Cancer 22:3, pages e319-e331.
Crossref
Crossref
Luana Barbosa Corrêa, Suyene Rocha Pinto, Luciana Magalhães Rebelo Alencar, Sotiris Missailidis, Elaine Cruz Rosas, Maria das Graças Muller de Oliveira Henriques & Ralph Santos-Oliveira. (2022) Nanoparticle conjugated with aptamer anti-MUC1/Y for inflammatory arthritis. Colloids and Surfaces B: Biointerfaces 211, pages 112280.
Crossref
Crossref
Ahmad Al Shihabi, Ardalan Davarifar, Huyen Thi Lam Nguyen, Nasrin TavanaieScott D. Nelson, Jane YanagawaNoah FedermanNicholas Bernthal, Francis HornicekAlice Soragni. (2022) Personalized chordoma organoids for drug discovery studies. Science Advances 8:7.
Crossref
Crossref
Gengle Niu, Jin Hao, Surui Sheng & Fangyuan Wen. (2021) Role of T‐box genes in cancer, epithelial‐mesenchymal transition, and cancer stem cells. Journal of Cellular Biochemistry 123:2, pages 215-230.
Crossref
Crossref
Francesco CAVALLI, Ermanno PUXEDDU, Elisa TEODORI, Maurizia SFORZA, Patrizia DE MARCO & Paola ROGLIANI. (2021) Biomarkers for possible early detection and progression of idiopathic pulmonary fibrosis. Minerva Respiratory Medicine 60:3.
Crossref
Crossref
Shane Patrick Flanagan, Ronen Fogel, Adrienne Lesley Edkins, Lance St. John Ho & Janice Limson. (2021) Nonspecific nuclear uptake of anti-MUC1 aptamers by dead cells: the role of cell viability monitoring in aptamer targeting of membrane-bound protein cancer biomarkers. Analytical Methods 13:9, pages 1191-1203.
Crossref
Crossref
Ludovic Peyre, Mickael Meyer, Paul Hofman & Jérémie Roux. (2020) TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms. British Journal of Cancer 124:1, pages 91-101.
Crossref
Crossref
Raefa Abou Khouzam, Hassan Venkatesh Goutham, Rania Faouzi Zaarour, Ali N Chamseddine, Amirtharaj Francis, Stéphanie Buart, Stéphane Terry & Salem Chouaib. (2020) Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Seminars in Cancer Biology 65, pages 140-154.
Crossref
Crossref
Margaret E. Gatti-Mays, Jason M. Redman, Renee N. Donahue, Claudia Palena, Ravi A. Madan, Fatima Karzai, Marijo Bilusic, Houssein Abdul Sater, Jennifer L. Marté, Lisa M. Cordes, Sheri McMahon, Seth M. Steinberg, Alanvin Orpia, Andrea Burmeister, Jeffrey Schlom, James L. Gulley & Julius Strauss. (2020) A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer. The Oncologist 25:6, pages 479-e899.
Crossref
Crossref
Lucas A. Horn, Kristen Fousek & Claudia Palena. (2020) Tumor Plasticity and Resistance to Immunotherapy. Trends in Cancer 6:5, pages 432-441.
Crossref
Crossref
Mohammad Zeeshan Ozair, Pavan Pinkesh Shah, Dimitrios Mathios, Michael Lim & Nelson S. Moss. (2020) New Prospects for Molecular Targets for Chordomas. Neurosurgery Clinics of North America 31:2, pages 289-300.
Crossref
Crossref
Zi Mei, Kai Zhang, Alfred King‐Yin Lam, Junwen Huang, Feng Qiu, Bin Qiao & Yi Zhang. (2019) MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma. Cancer Medicine 9:2, pages 640-652.
Crossref
Crossref
You Zou, Rui Yang, Mao-Ling Huang, Yong-Gang Kong, Jian-Fei Sheng, Ze-Zhang Tao, Ling Gao & Shi-Ming Chen. (2019) NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Xin GongSun, YongQiang Zhao, Bin Jiang, ZhongWei Xin, Mo Shi, Liang Song, QiMing Qin, Qiang Wang & XiangYan Liu. (2018) Inhibition of MUC1‐C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma. Journal of Cellular Physiology 234:7, pages 12019-12028.
Crossref
Crossref
Jingya Zhao, Mingxiang Feng, Dong Liu, Haixia Liu, Mengmeng Shi, Jing Zhang & Jieming Qu. (2019) Antagonism between HTRA3 and TGFβ1 Contributes to Metastasis in Non–Small Cell Lung Cancer. Cancer Research 79:11, pages 2853-2864.
Crossref
Crossref
Satomi Shiba, Atsushi Miki, Hideyuki Ohzawa, Takumi Teratani, Yasunaru Sakuma, Alan Kawarai Lefor, Joji Kitayama & Naohiro Sata. (2019) Functional Expression of Mucin1 in Human Duodenal Adenocarcinoma. Journal of Surgical Research 238, pages 79-89.
Crossref
Crossref
Elisabetta Romeo, Carmelo Antonio Caserta, Cristiano Rumio & Fabrizio Marcucci. (2019) The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System. Cells 8:5, pages 460.
Crossref
Crossref
Duane H. Hamilton, Kristen K. McCampbell & Claudia Palena. (2018) Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack. Frontiers in Oncology 8.
Crossref
Crossref
Hasan Rajabi, Masayuki Hiraki & Donald Kufe. (2018) MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells. Oncogene 37:16, pages 2079-2088.
Crossref
Crossref
Yumei Li, Changhua Zhou, Jing Li, Jiayu Liu, Limin Lin, Li Li, Donglin Cao, Qing Li & Zhong Wang. (2018) Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells. PLOS ONE 13:1, pages e0191024.
Crossref
Crossref
Takahiro Maeda, Masayuki Hiraki, Caining Jin, Hasan Rajabi, Ashujit Tagde, Maroof Alam, Audrey Bouillez, Xiufeng Hu, Yozo Suzuki, Masaaki Miyo, Tsuyoshi Hata, Kunihiko Hinohara & Donald Kufe. (2018) MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer. Cancer Research 78:1, pages 205-215.
Crossref
Crossref
A R Pyzer, D Stroopinsky, J Rosenblatt, E Anastasiadou, H Rajabi, A Washington, A Tagde, J-H Chu, M Coll, A L Jiao, L T Tsai, D E Tenen, L Cole, K Palmer, A Ephraim, R K Leaf, M Nahas, A Apel, M Bar-Natan, S Jain, M McMasters, L Mendez, J Arnason, B A Raby, F Slack, D Kufe & D Avigan. (2017) MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs. Leukemia 31:12, pages 2780-2790.
Crossref
Crossref
Christopher R. Heery, Claudia Palena, Sheri McMahon, Renee N. Donahue, Lauren M. Lepone, Italia Grenga, Ulrike Dirmeier, Lisa Cordes, Jenn Marté, William Dahut, Harpreet Singh, Ravi A. Madan, Romaine I. Fernando, Duane H. Hamilton, Jeffrey Schlom & James L. Gulley. (2017) Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury. Clinical Cancer Research 23:22, pages 6833-6845.
Crossref
Crossref
Charli Dominguez, Kristen K. McCampbell, Justin M. David & Claudia Palena. (2017) Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer. JCI Insight 2:21.
Crossref
Crossref
Hai Jiang, Xiaowei Wang, Wusheng Miao, Bing Wang & Yusheng Qiu. (2017) CXCL8 promotes the invasion of human osteosarcoma cells by regulation of PI3K/Akt signaling pathway. APMIS 125:9, pages 773-780.
Crossref
Crossref
Hasan Rajabi & Donald Kufe. (2017) MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 117-122.
Crossref
Crossref
Menglin Xu, Diane C. Wang, Xiangdong Wang & Yong Zhang. (2017) Correlation between mucin biology and tumor heterogeneity in lung cancer. Seminars in Cell & Developmental Biology 64, pages 73-78.
Crossref
Crossref
Ahmed M. Kabel. (2017) Tumor markers of breast cancer: New prospectives. Journal of Oncological Sciences 3:1, pages 5-11.
Crossref
Crossref
Athalia Rachel Pyzer, Dina StroopinskyHasan Rajabi, Abigail WashingtonAshujit Tagde, Maxwell CollJacqueline Fung, Mary Paty BryantLeandra ColeKristen PalmerPoorvi SomaiyaRebecca Karp LeafMyrna NahasArie ApelSalvia JainMalgorzata McMastersLourdes MendezJames LevineRobin JoyceJon ArnasonPier Paolo Pandolfi, Donald Kufe, Jacalyn RosenblattDavid Avigan. (2017) MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia. Blood 129:13, pages 1791-1801.
Crossref
Crossref
Duane H Hamilton, Mario Roselli, Patrizia Ferroni, Leopoldo Costarelli, Francesco Cavaliere, Mariateresa Taffuri, Claudia Palena & Fiorella Guadagni. (2016) Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer. Endocrine-Related Cancer 23:10, pages 783-796.
Crossref
Crossref
Justin David, Charli Dominguez, Duane Hamilton & Claudia Palena. (2016) The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance. Vaccines 4:3, pages 22.
Crossref
Crossref